BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2166697)

  • 1. IGF-I--stimulated glucose transport in human skeletal muscle and IGF-I resistance in obesity and NIDDM.
    Dohm GL; Elton CW; Raju MS; Mooney ND; DiMarchi R; Pories WJ; Flickinger EG; Atkinson SM; Caro JF
    Diabetes; 1990 Sep; 39(9):1028-32. PubMed ID: 2166697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of glucose uptake by insulin-like growth factor II in human muscle is not mediated by the insulin-like growth factor II/mannose 6-phosphate receptor.
    Burguera B; Elton CW; Caro JF; Tapscott EB; Pories WJ; Dimarchi R; Sakano K; Dohm GL
    Biochem J; 1994 Jun; 300 ( Pt 3)(Pt 3):781-5. PubMed ID: 8010960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects.
    Miele C; Formisano P; Condorelli G; Caruso M; Oriente F; Andreozzi F; Tocchetti CG; Riccardi G; Beguinot F
    Diabetologia; 1997 Apr; 40(4):421-9. PubMed ID: 9112019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An in vitro human muscle preparation suitable for metabolic studies. Decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects.
    Dohm GL; Tapscott EB; Pories WJ; Dabbs DJ; Flickinger EG; Meelheim D; Fushiki T; Atkinson SM; Elton CW; Caro JF
    J Clin Invest; 1988 Aug; 82(2):486-94. PubMed ID: 3403714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin action and glucose metabolism in nondiabetic control and NIDDM subjects. Comparison using human skeletal muscle cell cultures.
    Henry RR; Abrams L; Nikoulina S; Ciaraldi TP
    Diabetes; 1995 Aug; 44(8):936-46. PubMed ID: 7622000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose metabolism in incubated human muscle: effect of obesity and non-insulin-dependent diabetes mellitus.
    Friedman JE; Caro JF; Pories WJ; Azevedo JL; Dohm GL
    Metabolism; 1994 Aug; 43(8):1047-54. PubMed ID: 8052146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia stimulates glucose transport in insulin-resistant human skeletal muscle.
    Azevedo JL; Carey JO; Pories WJ; Morris PG; Dohm GL
    Diabetes; 1995 Jun; 44(6):695-8. PubMed ID: 7789635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of insulin-like growth factor I receptor in skeletal muscles of normal and insulin resistant subjects.
    Livingston N; Pollare T; Lithell H; Arner P
    Diabetologia; 1988 Dec; 31(12):871-7. PubMed ID: 2853680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle.
    Kelley DE; Mintun MA; Watkins SC; Simoneau JA; Jadali F; Fredrickson A; Beattie J; Thériault R
    J Clin Invest; 1996 Jun; 97(12):2705-13. PubMed ID: 8675680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM.
    Pedersen O; Bak JF; Andersen PH; Lund S; Moller DE; Flier JS; Kahn BB
    Diabetes; 1990 Jul; 39(7):865-70. PubMed ID: 2354749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of glycaemia on glucose transport in isolated skeletal muscle from patients with NIDDM: in vitro reversal of muscular insulin resistance.
    Zierath JR; Galuska D; Nolte LA; Thörne A; Kristensen JS; Wallberg-Henriksson H
    Diabetologia; 1994 Mar; 37(3):270-7. PubMed ID: 8174841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression of glucose transporter in muscle from insulin-resistant patients.
    Dohm GL; Elton CW; Friedman JE; Pilch PF; Pories WJ; Atkinson SM; Caro JF
    Am J Physiol; 1991 Mar; 260(3 Pt 1):E459-63. PubMed ID: 2003599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociation of in vitro sensitivities of glucose transport and antilipolysis to insulin in NIDDM.
    Yki-Järvinen H; Kubo K; Zawadzki J; Lillioja S; Young A; Abbott W; Foley JE
    Am J Physiol; 1987 Sep; 253(3 Pt 1):E300-4. PubMed ID: 3307452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-receptor autophosphorylation and endogenous substrate phosphorylation in human adipocytes from control, obese, and NIDDM subjects.
    Thies RS; Molina JM; Ciaraldi TP; Freidenberg GR; Olefsky JM
    Diabetes; 1990 Feb; 39(2):250-9. PubMed ID: 2227134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skeletal muscle fiber composition is related to adiposity and in vitro glucose transport rate in humans.
    Hickey MS; Carey JO; Azevedo JL; Houmard JA; Pories WJ; Israel RG; Dohm GL
    Am J Physiol; 1995 Mar; 268(3 Pt 1):E453-7. PubMed ID: 7900793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoration of insulin responsiveness in skeletal muscle of morbidly obese patients after weight loss. Effect on muscle glucose transport and glucose transporter GLUT4.
    Friedman JE; Dohm GL; Leggett-Frazier N; Elton CW; Tapscott EB; Pories WP; Caro JF
    J Clin Invest; 1992 Feb; 89(2):701-5. PubMed ID: 1737857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin action kinetics in adipocytes from obese and noninsulin-dependent diabetes mellitus subjects: identification of multiple cellular defects in glucose transport.
    Ciaraldi TP; Molina JM; Olefsky JM
    J Clin Endocrinol Metab; 1991 Apr; 72(4):876-82. PubMed ID: 2005215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular mechanisms of insulin resistance in non-insulin-dependent (type II) diabetes.
    Olefsky JM; Garvey WT; Henry RR; Brillon D; Matthaei S; Freidenberg GR
    Am J Med; 1988 Nov; 85(5A):86-105. PubMed ID: 3057897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM.
    Garvey WT; Maianu L; Hancock JA; Golichowski AM; Baron A
    Diabetes; 1992 Apr; 41(4):465-75. PubMed ID: 1535055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipose tissue glucose transporters in NIDDM. Decreased levels of muscle/fat isoform.
    Sinha MK; Raineri-Maldonado C; Buchanan C; Pories WJ; Carter-Su C; Pilch PF; Caro JF
    Diabetes; 1991 Apr; 40(4):472-7. PubMed ID: 2010047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.